US 12384853
Anti-HER2/PD1 bispecific antibody
granted A61KA61K2039/505A61P
Quick answer
US patent 12384853 (Anti-HER2/PD1 bispecific antibody) held by SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
- Grant date
- Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00